Take-all disease, caused by the fungal root pathogen Gaeumannomyces tritici, is considered to be the most important root disease of wheat worldwide. Here we review the advances in take-all research over the last 15 years, focusing on the identification of new sources of genetic resistance in wheat relatives and the role of the microbiome in disease development. We also highlight recent breakthroughs in the molecular interactions between G. tritici and wheat, including genome and transcriptome analyses. These new findings will aid the development of novel control strategies against take-all disease. In light of this growing understanding, the G. tritici-wheat interaction could provide a model study system for root-infecting fungal pathogens of cereals.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tplants.2021.02.009 | DOI Listing |
Vet Clin North Am Food Anim Pract
November 2024
Veterinary Education, Research, and Outreach Program, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, 3201 Russell Long Boulevard, Canyon, TX 79015, USA.
Biosecurity and infection control are important aspects of veterinary medicine and livestock production. In fact, cattle, sheep, and goat industries all rank biosecurity and disease prevention among the highest priority areas in livestock management. Although attention and planning have improved over the years among producers, the daily activities of a veterinarian can prevent or promote the spread of contagious disease agents.
View Article and Find Full Text PDFInt J Med Inform
February 2025
Department of Clinical Medicine, Miguel Hernández University, Elche, Spain; Cabo Huertas Health Centre, Department of Universal Health and Public Health, 03540 Alicante, Spain.
Introduction: Researchers conducting studies based on electronic health records (EHRs) often have to deal with missing data. We aimed to analyze patterns of missing data in lipid profile, sociodemographic variables and risk factors contained in the EHRs of the CARDIABETES project and compare different strategies for addressing the issue.
Methods: We conducted a retrospective cohort study of people with diabetes, based on EHRs in the Spanish Pharmacoepidemiological Research Database for Public Health Systems (BIFAP).
Clin Pharmacokinet
November 2024
Clinical Pharmacology, Bayer AG, Aprather Weg 18a, 42113, Wuppertal, Germany.
Introduction: Asundexian is a reversible and selective inhibitor of activated factor XI. It is currently under investigation for the prevention of secondary stroke in at-risk patients; these patients are often characterised by advanced age, impaired organ function and comorbidities. This article summarises results from three Phase I studies that investigated the effects of age and sex (study 1), chronic kidney disease including end-stage kidney disease (ESKD) on dialysis and dialysis-free days (study 2) and Child-Pugh A and B liver disease (study 3) on the safety, pharmacokinetics and pharmacodynamics of a single oral dose of asundexian 25 mg.
View Article and Find Full Text PDFFront Plant Sci
September 2024
Rothamsted Research, Strategic Areas: Protecting Crops and the Environment, Intelligent Data Ecosystems, Plant Sciences for the Bioeconomy, Harpenden, United Kingdom.
Take-all disease, caused by the Ascomycete fungus , is one of the most important root diseases of wheat worldwide. The fungus invades the roots and destroys the vascular tissue, hindering the uptake of water and nutrients. Closely related non-pathogenic species in the family, such as , occur naturally in arable and grassland soils and have previously been reported to reduce take-all disease in field studies.
View Article and Find Full Text PDFG Ital Cardiol (Rome)
October 2024
U.O. Cardiologia, Fondazione IRCCS San Gerardo dei Tintori, Monza (MB).
The last decade has seen a significant increase in the number of long survivors after a hematologic cancer, both children and adults, due to significant improvement in treatment. This exciting result, however, has been associated with an increase in the occurrence of previously unknown cardiovascular complications, including acute myocardial infarction, stroke, heart failure, deep vein thrombosis and pulmonary embolism. These adverse outcomes are due to both the hematologic cancer per se and to antineoplastic therapy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!